This contract expires in 72 days (Jan 4, 2027).
CHARTWELL RX LLC - DOXYCYCLINE HYCLATE 100 MG ORAL TABLETS
Key Details
Description
DOXYCYCLINE HYCLATE 100 MG ORAL TABLETS
Context & Analysis
On Dec 12, 2025, Department of Health and Human Services obligated $98,684,252.16 to CHARTWELL RX LLC for doxycycline hyclate 100 mg oral tablets. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 2 offers received. The procurement used a SMALL BUSINESS SET ASIDE - TOTAL set-aside. Performance is located in CONGERS, NY. The contract is scheduled through Jan 4, 2027 — approximately 2 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 325412 — related awards are listed below.
Market context
- Recompete outlook
- Ends Jan 4, 2027, in 2 months. Recompete signal as of Oct 15, 2026: 51/100, combining time to the end date, the incumbent's history with this agency, whether the award was competed, and its size.
- Competition
- Competed, with 2 offers. 93% of 131 awards in this market (Department of Health and Human Services awards in NAICS 325412 over the last 3 years) were competed; median 4 offers.
- Award size
- At $98.7M, this award is larger than three in four of the 127 priced Department of Health and Human Services awards in NAICS 325412 over the last 3 years (median $918K).
- Incumbent at this agency
- CHARTWELL RX LLC has 1 other award from Department of Health and Human Services, totalling $139.7M, in 2025.
- Largest vendors in this market
By obligations, Department of Health and Human Services awards in NAICS 325412 over the last 3 years.
- SANOFI VACCINES US INC. — 12 awards, $4.1B
- MERCK SHARP & DOHME LLC — 5 awards, $2.5B
- PFIZER INC — 6 awards, $1.2B
- GLAXOSMITHKLINE, LLC — 9 awards, $912.1M
- PHLOW CORP. — 1 award, $591.4M
Computed from USAspending award data on Oct 15, 2026.
Contractor Information
Similar Awards
VACCINES FOR CHILDREN FY25
MERCK SHARP & DOHME LLC
$2.5B
VACCINES FOR CHILDREN FY25
SANOFI VACCINES US INC.
$1.4B
END OF PWS
PFIZER INC
$1.1B
VACCINES FOR CHILDREN FY25
GLAXOSMITHKLINE, LLC
$793.0M
US BASED ADVANCED API MANUFACTURING. BASE PERIOD FUNDING FOR US BASED ADVANCED MANUFACTURING OF COVID-19 ESSENTIAL MEDICINES AND FUTURE THREATS.
PHLOW CORP.
$591.4M
Stay Updated
Get notified about new opportunities matching your interests.